Typhoid epidemiology, diagnostics and the human challenge model

Current Opinion in Gastroenterology

Volumn 30, Issue 1, 2014, Pages 7-17

  Darton, Thomas C ^a   Blohmke, Christoph J ^a   Pollard, Andrew J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

diagnostics; enteric fever; epidemiology; human challenge; typhoid

Indexed keywords

BICARBONATE; CIPROFLOXACIN; TYPHOID VACCINE;

AFRICA SOUTH OF THE SAHARA; ANTIBIOTIC RESISTANCE; ANTIGEN DETECTION; BLOOD CULTURE; DNA DETERMINATION; FECES CULTURE; GENE AMPLIFICATION; GENE DOSAGE; HUMAN; INCIDENCE; MALARIA CONTROL; MORBIDITY; PARATYPHOID FEVER; PNEUMOCOCCAL INFECTION; REVIEW; SALMONELLA PARATYPHI; SALMONELLA TYPHI; SALMONELLOSIS; SEROLOGY; TYPHOID FEVER;

AFRICA; HUMAN EXPERIMENTATION; HUMANS; MODELS, BIOLOGICAL; PARATYPHOID FEVER; PREVALENCE; SALMONELLA PARATYPHI A; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES;

EID: 84890422427     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000021     Document Type: Review

References (127)

1. Parry CM, Hien TT, Dougan G, et al. Typhoid fever. N Engl J Med 2002; 347:1770-1782.
2. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004; 82:346-353.
3. Maurice J. A first step in bringing typhoid fever out of the closet. The Lancet 2012; 379:699-700.
4. Pasetti MF, Levine MM, Sztein MB. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine 2003; 21:401-418.
5. Martin LB. Vaccines for typhoid fever and other salmonelloses. Curr Opin Infect Dis 2012; 25:489-499.
6. McGregor AC, Waddington CS, Pollard AJ. Prospects for prevention of Salmonella infection in children through vaccination. Curr Opin Infect Dis 2013; 26:254-262.
7. Crump JA, Ram PK, Gupta SK, et al. Part I. Analysis of data gaps pertaining to Salmonella enterica serotype Typhi infections in low and medium human development index countries, 1984-2005. Epidemiol Infect 2008; 136:436-448.
8. Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010. J Glob Health 2012; 2:10401. This is a recent update to current estimation of the global burden of both Salmonella Typhi and Paratyphi infections.
9. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095-2128. A hugely important recent study determining the leading causes of death in the global population, supported by the Bill & Melinda Gates Foundation. By all causes, typhoid is ranked as the 35th leading cause of years of life lost. See also the interactive figures available online at: Http:// healthmetricsandevaluation.org/gbd/visualizations/regional [accessed 31 August 2013]
10. ProMed-mail. Typhoid Fever Update 2008 (07).
11. ProMED-mail 2008; 18 Nov: 20081118.3640. http://www.promedmail.org. [Accessed 31 August 2013]
12. ProMed-mail. Typhoid Fever Update 2008 (08).
13. ProMED-mail 2008; 29 Dec: 20081229.4095. http://www.promedmail.org. [Accessed 31 August 2013]
14. ProMed-mail. Typhoid Fever-USA (Tennessee) Cluster.
15. ProMED-mail 2009; 8 Jun: 20090908.2120. http://www.promedmail.org>. [Accessed 31 August 2013]
16. ProMed-mail. Typhoid Fever Update 2009 (01).
17. ProMED-mail 2009 10 Jul: 20090710.2472. < http://www.promedmail. org> [Accessed 31 August 2013]
18. ProMed-mail. Typhoid Fever Update 2010 (01) Tourists, Nepal.
19. ProMEDmail 2010 11 Jan: 20100111.0125. [Accessed 31 August 2013]
20. ProMed-mail. Typhoid Fever Update 2010 (03) Fiji (Northern), Alert.
21. ProMED-mail 2010; 09 Mar: 20100309.0763. http://www.promedmail. org>. [Accessed 31 August 2013]
22. ProMed-mail. Typhoid Fever-USA (02): (CA,NV) fruit pulp, recall.
23. ProMEDmail 2010; 22 Aug: 20100822.2937. http://www.promedmail.org>. [Accessed 31 August 2013]
24. ProMed-mail. Typhoid Fever-India (HR). ProMED-mail 2010; 29 Aug: 20100829.3076. http://www.promedmail.org>. [Accessed 31 August 2013]
25. ProMed-mail. Typhoid Fever Update 2012 (07).
26. ProMED-mail 2012; 17 Mar: 20120317.1073326. http://www.promedmail. org>. [Accessed 31 August 2013]
27. ProMed-mail. Typhoid Fever Update 2012.
28. ProMED-mail 2012; 10 Jan: 20120110.1005781. http://www.promedmail. org>. [Accessed 31 August 2013]
29. ProMed-mail. Typhoid Fever Update 2012 (11): Zimbabwe (Harare).
30. ProMED-mail 2012; 14 Jun: 20120614.1168345. http://www.promed mail.org>. [Accessed 31 August 2013]
31. ProMed-mail. Typhoid Fever Update 2012 (04: Zambia).
32. ProMED-mail 2012; 09 Feb: 20120209.1037372. http://www.promedmail. org>. [Accessed 31 August 2013]
33. ProMed-mail. Typhoid Fever Update 2012 (05): Zimbabwe, India.
34. ProMEDmail 2012; 12 Feb: 20120212.1039842. http://www.promedmail.org>. [Accessed 31 August 2013]
35. ProMed-mail. Typhoid Fever Update 2012 (08): Oceania.
36. ProMED-mail 2012; 21 Mar: 20120321.1076101. http://www.promedmail. org>. [Accessed 31 August 2013]
37. ProMed-mail. Typhoid Fever Update 2012 (06).
38. ProMED-mail 2012; 10 Mar: 20120310.1065939. http://www.promedmail. org>. [Accessed 31 August 2013]
39. ProMed-mail. Typhoid Fever Update 2012 (09).
40. ProMED-mail 2012; 20 Apr: 20120420.1107274. http://www.promedmail. org>. [Accessed 31 August 2013]
41. ProMed-mail. Typhoid Update-Taiwan (ex Myanmar), Zimbabwe.
42. ProMEDmail 2012; 25 Mar: 20120325.1602504. http://www.promedmail.org>. [Accessed 31 August 2013]
43. ProMed-mail. Typhoid Update-USA (CA), Infected Food, Alert.
44. ProMEDmail 2013; 06 May: 20130506.1695411. http://www.promedmail.org>. [Accessed 31 August 2013]
45. ProMed-mail. Typhoid Fever Update 2013 (02).
46. ProMED-mail 2013; 08 May: 20130508.1697417. http://www.promedmail. org>. [Accessed 31 August 2013]
47. ProMed-mail. Typhoid Fever Update 2013 (03).
48. ProMED-mail 2013; 13 May: 20130513.1701630. http://www.promedmail. org>. [Accessed 31 August 2013]
49. ProMed-mail.Typhoid Fever Update 2013 (04): India, Fiji.
50. ProMED-mail 2013; 06 Jun: 20130606.1756079. http://www.promedmail. org>. [Accessed 31 August 2013]
51. ProMed-mail. Typhoid Fever Update 2013 (05): American Samoa, Philippines.
52. ProMED-mail 2013; 18 Jun: 20130618.1779531. http://www. promedmail.org>. [Accessed 31 August 2013]
53. Crump JA. Typhoid Fever and the challenge of nonmalaria febrile illness in sub-saharan Africa. Clin Infect Dis 2012; 54:1107-1109.
54. Feasey NA, Archer BN, Heyderman RS, et al. Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa. Emerg Infect Dis 2010; 16:1448-1451.
55. Mweu E, English M. Typhoid fever in children in Africa. Trop Med Int Health 2008; 13:532-540.
56. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352:39-47.
57. Levine MM, Farag TH. Invasive salmonella infections and HIV in Northern Tanzania. Clin Infect Dis 2011; 52:349-351.
58. Marks F, Adu-Sarkodie Y, Hunger F, et al. Typhoid fever among children, Ghana. Emerg Infect Dis 2010; 16:1796-1797.
59. Thriemer K, Ley BB, Ame SS, et al. Clinical and epidemiological features of typhoid fever in Pemba, Zanzibar: Assessment of the performance of the WHO case definitions. PLoS One 2012; 7:e51823.
60. Crump JA, Ramadhani HO, Morrissey AB, et al. Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania. Clin Infect Dis 2011; 52:341-348
61. Neil KP Sodha SV Lukwago L et al. A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda Clin Infect Dis 2012 54 1091-1099 A recent report of a large typhoid outbreak in Uganda, highlighting the issues of adequate surveillance and timely antibiotic treatment in preventing the usually uncommon but life-threatening complications of infection.
62. Lutterloh E, Likaka A, Sejvar J, et al. Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis 2012; 54:1100-1106. In an almost parallel report to that above, this study describes an outbreak of MDR typhoid associated with unusual neurological presentations with the use of a rapid antibody-based diagnostic because of the inavailability of culture facilities.
63. Breiman RF, Cosmas L, Njuguna H, et al. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: Implications for typhoid vaccine use in Africa. PLoS One 2012; 7:e29119.
64. Lunguya O, Lejon V, Phoba MF, et al. Salmonella typhi in the democratic republic of the congo: Fluoroquinolone decreased susceptibility on the rise. PLoS Negl Trop Dis 2012; 6:e1921.
65. Lunguya O, Phoba M-F, Mundeke SA, et al. The diagnosis of typhoid fever in the Democratic Republic of the Congo. Trans R Soc Trop Med Hyg 2012; 106:348-355.
66. Kingsley RA, Msefula CL, Thomson NR, et al. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 2009; 19:2279-2287.
67. Okoro CK, Kingsley RA, Connor TR, et al. Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nat Genet 2012; 44:1215-1221.
68. Ochiai RL, Wang X, von Seidlein L, et al. Salmonella paratyphi A rates, Asia. Emerg Infect Dis 2005; 11:1764-1766.
69. Crump JA, Mintz ED. Global trends in typhoid and paratyphoid fever. Clin Infect Dis 2010; 50:241-246.
70. Chandrasiri P, Elwitigala JP, Nanayakkara G, et al. A multi centre laboratory study of Gram negative bacterial blood stream infections in Sri Lanka. Ceylon Med J 2013; 58:56-61.
71. Andrews JR, Prajapati KG, Eypper E, et al. Evaluation of an electricity-free, culture-based approach for detecting typhoidal Salmonella bacteremia during enteric fever in a high burden, resource-limited setting. PLoS Negl Trop Dis 2013; 7:e2292. An interesting recent study investigating a pragmatic approach to improve culturebased diagnostics in resource-limited settings.
72. Raza S, Tamrakar R, Bhatt CP, Joshi SK. Antimicrobial susceptibility patterns of Salmonella typhi and Salmonella paratyphi A in a tertiary care hospital. J Nepal Health Res Counc 2012; 10:214-217.
73. Choudhary A, Gopalakrishnan R, Nambi PS, et al. Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India. Indian J Med Res 2013; 137:800-802.
74. Liang W, Zhao Y, Chen C, et al. Pan-genomic analysis provides insights into the genomic variation and evolution of Salmonella Paratyphi A. PLoS One 2012; 7:e45346.
75. McClelland M, Sanderson KE, Clifton SW, et al. Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet 2004; 36:1268-1274.
76. Dongol S, Thompson CN, Clare S, et al. The microbiological and clinical characteristics of invasive salmonella in gallbladders from cholecystectomy patients in kathmandu, Nepal. PLoS One 2012; 7:e47342.
77. Gal-Mor O, Suez J, Elhadad D, et al. Molecular and cellular characterization of a Salmonella enterica Serovar Paratyphi A outbreak strain and the human immune response to infection. Clin Vaccine Immunol 2011; 19:146-156.
78. Leder K, Torresi J, Brownstein JS, et al. Travel-associated illness trends and clusters. Emerg Infect Dis 2013; 19:1049-1073.
79. Addiman S, Maimaris W, Thomas HL, et al. Public health management of salmonella typhi/paratyphi case and contact screening: Lessons from North London. Public Health 2013; 127:207-213.
80. Balasegaram S, Potter AL, Grynszpan D, et al. Guidelines for the public health management of typhoid and paratyphoid in England: Practice guidelines from the National Typhoid and Paratyphoid Reference Group. J Infect 2012; 65:197-213.
81. Blackstock SJ, Sheppeard VK, Paterson JM, Ralph AP. Typhoid and paratyphoid fever in Western Sydney Local Health District, NSW, January-June 2011. N S W Public Health Bull 2012; 23:148-152.
82. Vrbova L, Johnson K, Whitfield Y, Middleton D. A descriptive study of reportable gastrointestinal illnesses in Ontario, Canada, from 2007 to 2009. BMC Public Health 2012; 12:970.
83. Jensenius M, Han PV, Schlagenhauf P, et al. Acute and potentially lifethreatening tropical diseases in western travelers: A GeoSentinel multicenter study. Am J Trop Med Hyg 2013; 88:397-404.
84. Molloy A, Nair S, Cooke FJ, et al. First report of Salmonella enterica Serotype Paratyphi A Azithromycin resistance leading to treatment failure. J Clin Microbiol 2010; 48:4655-4657.
85. Hassing RJ, Goessens WH, Mevius DJ, et al. Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: The impact on clinical outcome and future treatment options. Eur J Clin Microbiol Infect Dis 2013; 32:1295-1301.
86. Parry CM, Wijedoru L, Arjyal A, Baker S. The utility of diagnostic tests for enteric fever in endemic locations. Expert Rev Anti Infect Ther 2011; 9:711-725.
87. World Health Organization. Background document: The diagnosis, treatment and prevention of typhoid fever. Geneva: WHO: Department of Vaccines and Biologicals; 2003. (WHO/V&B/03.07).
88. World Health Organization. Report of the ad-hoc consultation on typhoid vaccine introduction and typhoid surveillance. Geneva: WHO: Department of Immunization, Vaccines and Biologicals; 2012. (WHO/IVB/12.02).
89. Cunha BA, Gran A, Munoz-Gomez S. Typhoid fever vs. malaria in a febrile returning traveler: Typhomalaria revisited-an Oslerian perspective. Travel Med Infect Dis 2013; 11:66-69.
90. Farmakiotis D, Varughese J, Sue P, et al. Typhoid fever in an inner city hospital: A 5-year retrospective review. J Travel Med 2013; 20:17-21.
91. Wain J, Hosoglu S. The laboratory diagnosis of enteric fever. J Infect Dev Ctries 2008; 2:421-425.
92. Zhou L, Darton T, Waddington CS, Pollard AJ. Molecular diagnosis of enteric fever: Progress and perspectives. In: Annous B, editor. Salmonella: Distribution, adaptation, control measures and molecular technologies. In-Tech; 2012.www.intechopen.com/books/salmonella-distribution-adaptationcontrol- measures-and-molecular-technologies/molecular-diagnosis-of-entericfever- progress-and-perspectives. [Accessed 30 September 2013]
93. Wain J, Pham VB, Ha V, et al. Quantitation of bacteria in bone marrow from patients with typhoid fever: Relationship between counts and clinical features. J Clin Microbiol 2001; 39:1571-1576.
94. Baker S, Favorov M, Dougan G. Searching for the elusive typhoid diagnostic. BMC Infect Dis 2010; 10:45.
95. Wain J, Diep TS, Ho VA, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 1998; 36:1683-1687.
96. Olopoenia LA, King AL. Widal agglutination test: 100 years later-still plagued by controversy. Postgrad Med J 2000; 76:80-84.
97. Pal S, Prakash R, Juyal D, et al. The baseline widal titre among the healthy individuals of the hilly areas in the garhwal region of uttarakhand, India. J Clin Diagn Res 2013; 7:437-440.
98. ParryCM, Hoa NT, Diep TS, et al. Value of a single-tube widal test in diagnosis of typhoid fever in Vietnam. J Clin Microbiol 1999; 37:2882-2886.
99. Greenhill A, Siba V, Horwood P. Reply to 'apropos ''evaluation of serological diagnostic tests for typhoid Fever in papua new Guinea using a composite reference standard'''. Clin Vaccine Immunol 2013; 20:318.
100. Keddy KH, Sooka A, Letsoalo ME, et al. Sensitivity and specificity of typhoid fever rapid antibody tests for laboratory diagnosis at two sub-Saharan African sites. Bull World Health Organ 2011; 89:640-647.
101. Siba V, Horwood PF, Vanuga K, et al. Evaluation of serological diagnostic tests for typhoid fever in Papua New Guinea using a composite reference standard. Clin Vaccine Immunol 2012; 19:1833-1837.
102. Banoo S, Bell D, Bossuyt P, et al. Evaluation of diagnostic tests for infectious diseases: General principles. Nat Rev Microbiol 2006; 4:S21-31.
103. Liang L, Juarez S, Nga TVT, et al. Immune profiling with a Salmonella Typhi antigen microarray identifies new diagnostic biomarkers of human typhoid. Sci Rep 2013; 3:1043.
104. Harris JB, Baresch-Bernal A, Rollins SM, et al. Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi. Infect Immun 2006; 74:5161-5168.
105. Alam MM, Tsai LL, Rollins SM, et al. Identification of in vivo-induced bacterial proteins during human infection with Salmonella enterica serotype Paratyphi A. Clin Vaccine Immunol 2013; 20:712-719.
106. Charles RC, Sultana T, Alam MM, et al. Identification of Immunogenic Salmonella enterica Serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, Nepal. PLoS Negl Trop Dis 2013; 7:e2335.
107. Khanam F, Sheikh A, Sayeed A, et al. Evaluation of a typhoid/paratyphoid diagnostic assay (TPTest) detecting anti-Salmonella IgA in secretions of peripheral blood lymphocytes in patients in Dhaka, Bangladesh. PLoS Negl Trop Dis 2013; 7:e2316.
108. Castonguay-Vanier J, Davong V, Bouthasavong L, et al. Evaluation of a simple blood culture amplification and antigen detection method for diagnosis of Salmonella enterica Serovar Typhi Bacteremia. J Clin Microbiol 2012; 51:142-148.
109. Nugraha J, Marpaung FR, Tam FCH, Lim PL. Microbiological culture simplified using anti-O12 monoclonal antibody in TUBEX test to detect Salmonella bacteria from blood culture broths of enteric fever patients. PLoS One 2012; 7:e49586.
110. Nga T, Karkey A, Dongol S, et al. The sensitivity of real-time PCR amplification targeting invasive Salmonella serovars in biological specimens. BMC Infect Dis 2010; 10:125.
111. Zhou L, Pollard AJ. A fast and highly sensitive blood culture PCR method for clinical detection of Salmonella enterica serovar Typhi. Ann Clin Microbiol Antimicrob 2010; 9:14.
112. Zhou L, Pollard AJ. A novel method of selective removal of human DNA improves PCR sensitivity for detection of Salmonella Typhi in blood samples. BMC Infect Dis 2012; 12:164.
113. Levine MM, Tacket CO, Sztein MB. Host-Salmonella interaction: Human trials. Microbes Infect 2001; 3:1271-1279.
114. de Jong HK, Parry CM, Van Der Poll T, Wiersinga WJ. Host-pathogen interaction in invasive Salmonellosis. PLoS Pathog 2012; 8:e1002933. A good recent summary of our current understanding regarding Salmonella pathogenesis in humans.
115. O'Brien AD. Innate resistance of mice to Salmonella typhi infection. Infect Immun 1982; 38:948-952.
116. Hormaeche CE, Harrington KA, Joysey HS. Natural resistance to salmonellae in mice: Control by genes within the major histocompatibility complex. J Infect Dis 1985; 152:1050-1056.
117. Santos RL, Zhang S, Tsolis RM, et al. Animal models of Salmonella infections: Enteritis versus typhoid fever. Microbes Infect 2001; 3:1335-1344.
118. Sabbagh SC, Forest CG, Lepage C, et al. So similar, yet so different: Uncovering distinctive features in the genomes of Salmonella enterica serovars Typhimurium and Typhi. FEMS Microbiol Lett 2010; 305:1-13.
119. Song J, Gao X, Galan JE. Structure and function of the Salmonella Typhi chimaeric AB typhoid toxin. Nature 2013; 499:350-354.
120. Mathur R, Oh H, Zhang D, et al. A mouse model of Salmonella typhi infection. Cell 2012; 151:590-602.
121. Fang FC, Baumler AJ. A tollgate for typhoid. Cell 2012; 151:473-475.
122. Hornick RB, Greisman SE, Woodward TE, et al. Typhoid fever: Pathogenesis and immunologic control. N Engl J Med 1970; 283:686-691.
123. Kotloff KL, Nataro JP, Losonsky GA, et al. A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: Clinical experience and implications for Shigella infectivity. Vaccine 1995; 13:1488-1494.
124. Gorden J, Small PL. Acid resistance in enteric bacteria. Infect Immun 1993; 61:364-367.
125. Harro C, Chakraborty S, Feller A, et al. Refinement of a human challenge model for evaluation of enterotoxigenic Escherichia coli vaccines. Clin Vaccine Immunol 2011; 18:1719-1727.
126. Glynn JR, Hornick RB, Levine MM, Bradley DJ. Infecting dose and severity of typhoid: Analysis of volunteer data and examination of the influence of the definition of illness used. Epidemiol Infect 1995; 115:23-30.
127. Snyder MJ, Hornick RB, McCrumb FR Jr, et al. Asymptomatic typhoidal bacteremia in volunteers. Antimicrob Agents Chemother (Bethesda) 1963; 161:604-607.